What does CUSIP 14740B606 represent in this 13F holders report?

CUSIP 14740B606 is the security identifier for CASC - CASCADIAN THERAPEUTICS INC - COM NEW used to aggregate holder disclosures.

How many institutions held CASC - CASCADIAN THERAPEUTICS INC - COM NEW in Q1 2018?

No institutional holders were reported for CASC - CASCADIAN THERAPEUTICS INC - COM NEW in Q1 2018; review adjacent reporting periods for trend context.

CASCADIAN THERAPEUTICS INC - COM NEW (CASC)

CUSIP: 14740B606

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / COM NEW
Total 13F shares: 0
Share change: -41,069,177
Total reported value: $0
Number of holders: 0
Value change: -$151,967,427
Number of sells: 81

Quarterly Holders Quick Answers

What is CUSIP 14740B606?
CUSIP 14740B606 identifies CASC - CASCADIAN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2017

Recent filing periods for CUSIP 14740B606:

Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016

CASCADIAN THERAPEUTICS INC - COM NEW (CASC)

Q1 2018 13F Holders as of 31 Mar 2018

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CASC - CASCADIAN THERAPEUTICS INC - COM NEW as of Q1 2018.